Thomas Kruse

1.3k total citations · 1 hit paper
9 papers, 923 citations indexed

About

Thomas Kruse is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Surgery. According to data from OpenAlex, Thomas Kruse has authored 9 papers receiving a total of 923 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Endocrinology, Diabetes and Metabolism, 7 papers in Molecular Biology and 5 papers in Surgery. Recurrent topics in Thomas Kruse's work include Diabetes Treatment and Management (7 papers), Pancreatic function and diabetes (5 papers) and Metabolism, Diabetes, and Cancer (5 papers). Thomas Kruse is often cited by papers focused on Diabetes Treatment and Management (7 papers), Pancreatic function and diabetes (5 papers) and Metabolism, Diabetes, and Cancer (5 papers). Thomas Kruse collaborates with scholars based in Denmark and Australia. Thomas Kruse's co-authors include Lauge Schäffer, Jesper Lau, Lotte Bjerre Knudsen, Jacob Kofoed, J. H. McGuire, Dorte X. Gram, Jane C. Spetzler, Holger M. Strauss, Sanne Møller Knudsen and Ingrid Pettersson and has published in prestigious journals such as PLoS ONE, Nature Chemistry and Journal of Medicinal Chemistry.

In The Last Decade

Thomas Kruse

8 papers receiving 906 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Discovery of the Once-Weekly Glucagon-Like Peptide-1 (GLP-1) Analogue Semaglutide

2015 736 citations Jesper Lau, Lauge Schäffer et al. Journal of Medicinal Chemistry profile →

Peers

Thomas Kruse

MB

EDM

SURGE

CMN

PHARM

Renée Komorowski United States

Élie Besserer‐Offroy Canada

Paul DaSilva‐Jardine United States

Yoshiro Kitahara Japan

Craig Weber United States

Morten Lundh Denmark

Marie‐Pierre Pruniaux France

Jonatan Tuncel Sweden

Nigel Beaton Switzerland

J. Nilsson Sweden

Renée Komorowski United States

Thomas Kruse

544 ×1.0

MB

430 ×0.8

EDM

302 ×1.4

SURGE

87 ×0.5

CMN

113 ×0.7

PHARM

Citations per year, relative to Thomas Kruse Thomas Kruse (= 1×) peers Renée Komorowski

Countries citing papers authored by Thomas Kruse

Since Specialization

Citations

This map shows the geographic impact of Thomas Kruse's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Kruse with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Kruse more than expected).

Fields of papers citing papers by Thomas Kruse

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Kruse. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Kruse. The network helps show where Thomas Kruse may publish in the future.

Co-authorship network of co-authors of Thomas Kruse

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Kruse. A scholar is included among the top collaborators of Thomas Kruse based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Kruse. Thomas Kruse is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Kuhre, Rune E., Christian L. Brand, Tine Glendorf, et al.. (2025). The effect of amycretin, a unimolecular glucagon-like peptide-1 and amylin receptor agonist, on body weight and metabolic dysfunction in mice and rats. EBioMedicine. 118. 105862–105862. 5 indexed citations

2.

Kruse, Thomas & Søren Østergaard. (2024). Redefining peptide therapeutics with semaglutide. Nature Chemistry. 16(2). 296–296.

3.

Galsgaard, Katrine D., Samuel A.J. Trammell, Marie Winther‐Sørensen, et al.. (2022). Opposing effects of chronic glucagon receptor agonism and antagonism on amino acids, hepatic gene expression, and alpha cells. iScience. 25(11). 105296–105296. 17 indexed citations

4.

Simonsen, Lotte, Jesper Lau, Thomas Kruse, et al.. (2022). Preclinical evaluation of a protracted GLP-1/glucagon receptor co-agonist: Translational difficulties and pitfalls. PLoS ONE. 17(3). e0264974–e0264974. 26 indexed citations

5.

Kruse, Thomas, Jakob Lerche Hansen, Kirsten Dahl, et al.. (2021). Development of Cagrilintide, a Long-Acting Amylin Analogue. Journal of Medicinal Chemistry. 64(15). 11183–11194. 76 indexed citations

6.

Fletcher, Madeleine M., Peter Keov, Tin T. Truong, et al.. (2021). AM833 Is a Novel Agonist of Calcitonin Family G Protein–Coupled Receptors: Pharmacological Comparison with Six Selective and Nonselective Agonists. Journal of Pharmacology and Experimental Therapeutics. 377(3). 417–440. 45 indexed citations

7.

John, Linu M., Thomas Kruse, & Kirsten Raun. (2021). Preclinical Weight Loss Efficacy of AM833 in Combination With Semaglutide in Rodent Models of Obesity. Journal of the Endocrine Society. 5(Supplement_1). A54–A54. 7 indexed citations

8.

Kruse, Thomas, et al.. (2019). Structure–Activity Relationships and Characterization of Highly Selective, Long-Acting, Peptide-Based Cholecystokinin 1 Receptor Agonists. Journal of Medicinal Chemistry. 62(3). 1407–1419. 11 indexed citations

9.

Lau, Jesper, Lauge Schäffer, Ingrid Pettersson, et al.. (2015). Discovery of the Once-Weekly Glucagon-Like Peptide-1 (GLP-1) Analogue Semaglutide. Journal of Medicinal Chemistry. 58(18). 7370–7380. 736 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact